Thursday, January 15, 2026
4:00 PM – 5:00 PM UTC
5:00 PM – 6:00 PM CET
11:00 AM – 12:00 PM EST
Learning Objectives:
- Understand the therapeutic potential and toxicity profile of antibody-drug conjugates (ADCs)
- Recognize, prevent and manage ADC-induced oral mucositis
- Understand the patient’s perception of mucositis and integrate patient-reported outcomes into supportive care planning
Agenda:
- Introduction – Prof. Paolo Bossi and Prof. Florian Scotté (Chairs)
- Antibody-drug Conjugates: Clinical Data and On-target/Off-tumor Toxicities – Dr. Barbara Pistilli
- Prevention and Treatment of ADC-induced Mucositis: Back to the Past? – Dr. Emmanuelle Vigarios
- The Patient’s Point of View on Oral Mucositis – Dr. Helen Bulbeck
- Q & A
Speakers:
Prof. Florian Scotté
(Co-Chair)
Prof. Paolo Bossi
(Co-Chair)
Dr. Barbara Pistilli
Dr. Emmanuelle Vigarios
Dr. Helen Bulbeck
This webinar is made possible by an unrestricted grant from Daiichi Sankyo Europe
